About ROTAVAC 5D ®

rotavac,first indian designed vaccine to pass WHO

A new variant of rotavirus vaccine (ROTAVAC®) ROTAVAC 5D®, is the world’s first and only liquid formulation with lowest dosage form & can be stored at 2-8°C.
ROTAVAC 5D® is a monovalent vaccine containing suspension of live, naturally attenuated rotavirus neonatal 116E strain prepared in Vero cells for the prevention of rotavirus gastroenteritis. Each dose of 0.5 mL ROTAVAC 5D® contains not less than [NLT] 105.0 FFU [Focus forming unit] of live rotavirus 116E & is administered in five drops as a 3-dose regimen, 4 weeks apart, beginning at 6 weeks of age.

ROTAVAC 5D® is a unique rotavirus vaccine formulation that can be administered without buffer. Low dose facilitates easy vaccine logistics and cold chain management, and low biomedical waste disposal post-vaccination.

It can be stored at 2-8°C for up to 24 months. ROTAVAC 5D® confers similar clinical safety and immunogenicity profiles when compared to the WHO Prequalified ROTAVAC®. It is available in three different presentations, single-dose vial/pre-filled syringe and multi-dose vial. The available presentations and lowest dosage form makes it convenient and easy to adapt under Universal Immunization Programs (UIP) by countries.

Patient Product Information

Prescribing Information

Rotavac 5D Brochure